Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 2 Study of Circulating Tumor Cell in Non-Small Cell Lung Carcinoma

NCT01830426 is registered in ClinicalTrials.gov with Epic Sciences as lead sponsor.

NCT NCT01830426
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01830426 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 2 Study of Circulating Tumor Cell in Non-Small Cell Lung Carcinoma
Lead sponsor
Epic Sciences
Phase
Observational
Overall status
Completed
Start date
November 30, 2012
Completion date
January 31, 2016
Enrollment
232 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

primary lung cancer